News & Events
Dr. Peter Lassota joined BioVirtus as an Executive Scientific Advisor in drug development
It is our pleasure to announce that Dr. Peter Lassota joined BioVirtus as an Executive Scientific Advisor in drug development.
Dr. Lassota is a seasoned, executive level drug hunter with more than 20 years of successful experience in oncology R&D at major US Pharma companies, including American Cyanamid, Wyeth and Novartis.
His skills and expertise will nicely complement current BioVirtus capabilities, and will strengthen our ability to help customers develop their drug candidates quickly and cost-effectively.
Hiring Dr. Lassota is in line with the BioVirtus goal to become comprehensive provider of drug development services.